|Articles|November 4, 2022
Inato Announces Platform Enhancements
Enhancements will help community research sites offer more clinical trials by streamlining trial matching with pharma sponsors.
Advertisement
Inato has announced its latest platform enhancements. The enhancements will help community research sites offer more clinical trials in their communities by streamlining trial matching with pharma sponsors and reducing redundancies in the trial enrollment process.
Read more about the platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Breaking Out of AI Pilot Mode in Clinical Development
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5